---
title: "GLMD Q2'26 Earnings: EPS estimate is (0.39) USD"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293603497.md"
description: "GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported—————Revenue Estimate1.45 M1.37 M1.30 M——Revenue SurpriseEPS Reported(0.63)(0.33)(0.80)(0.38) EPS Estimate(0.83)(0.54)(0.51)(0.38)(0.39) EPS Surprise+24.10%+38.89%-56.86%+0.00%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc."
datetime: "2026-07-23T11:01:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293603497.md)
  - [en](https://longbridge.com/en/news/293603497.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293603497.md)
generator: "portal-rs"
---

# GLMD Q2'26 Earnings: EPS estimate is (0.39) USD

GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).

For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at .

**Revenue & EPS values are provided in USD**

|                      | Q2'25   | Q3'25   | Q4'25   | Q1'26  | Q2'26  |
| -------------------- | ------- | ------- | ------- | ------ | ------ |
| **Revenue Reported** | —       | —       | —       | —      | —      |
| **Revenue Estimate** | 1.45 M  | 1.37 M  | 1.30 M  | —      | —      |
| **Revenue Surprise** |         |         |         |        |        |
| **EPS Reported**     | (0.63)  | (0.33)  | (0.80)  | (0.38) |        |
| **EPS Estimate**     | (0.83)  | (0.54)  | (0.51)  | (0.38) | (0.39) |
| **EPS Surprise**     | +24.10% | +38.89% | -56.86% | +0.00% |        |

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.

### Related Stocks

- [GLMD.US](https://longbridge.com/en/quote/GLMD.US.md)

## Related News & Research

- [Galmed amends AGM proxy materials ahead of Sept. 2 shareholder vote](https://longbridge.com/en/news/296394814.md)
- [Galmed says Colospan intraoperative colon tissue assessment study meets feasibility goal in first-in-human trial](https://longbridge.com/en/news/296343802.md)
- [SoftwareOne attaches full H1 2026 report in correction to earlier release](https://longbridge.com/en/news/297010247.md)
- [Cemat publishes H1 2026 interim report](https://longbridge.com/en/news/297006906.md)
- [Ameriprise Financial declares Q3 2026 dividend of R$ 1.48 per unit](https://longbridge.com/en/news/297021432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**